News Search Results
Feb 26, 2026, 06:10 ET Three CrossFit Sessions for Cancer Survivors Beginning Soon in Genesee, Oakland and Wayne Counties
outcomes experienced by African American cancer survivors. Both studies reveal that cancer survivors who meet ACS's exercise recommendations report less insomnia and better sleep quality, showing that exercise is a benefit to cancer survivors. The team has previously shown that sleep health is one of the most
More news about: Karmanos Cancer Institute
Feb 24, 2026, 16:01 ET Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
the company's next chapter.Workday welcomed new customers including Boston Children's Hospital, Copenhagen Airports A/S, Fruit of the Loom, Insomnia Cookies, Lavazza, Sargent & Lundy, State of New York Unified Court System, and Queensland University of Technology, and expanded existing relationships
More news about: Workday Inc.
Feb 18, 2026, 08:00 ET Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.
More news about: Lipocine Inc.
Feb 17, 2026, 14:39 ET Unlikely Collaborators Hosts Dr. Jade Wu: Why Sleep Changes How Everything Feels
also be livestreamed online. In-person attendees will receive a complimentary copy of Dr. Wu's book Hello Sleep: The Science and Art of Overcoming Insomnia Without Medications.Event Schedule6:00 p.m. — Doors open and reception7:00 p.m. — Program begins promptly8:00
More news about: Unlikely Collaborators
Feb 17, 2026, 14:02 ET Cindy Eckert, Women's Health Innovator, Named to TIME's 2026 TIME100 Health List of the World's Most Influential Leaders in Health
Most Common Adverse ReactionsMost common adverse reactions (incidence ≥2%) are dizziness, somnolence, nausea, fatigue, insomnia, urinary tract infection, anxiety, sinusitis, constipation, and dry mouth.See Full Prescribing Information and Medication Guide, including
More news about: Sprout Pharmaceuticals
Feb 17, 2026, 10:03 ET Tennessee Oncology and OncoveryCare Expand Survivorship Care
Cancer survivors can face significant challenges, including cancer-related fatigue and functional limitation; cardiotoxicity, sexual dysfunction, and insomnia; anxiety and depression linked to cancer diagnosis; and more. Despite these growing needs, the management of survivorship remains fragmented and unstructured,
More news about: Tennessee Oncology
Feb 17, 2026, 08:30 ET Sanofi announces leadership evolution in Specialty Care Business Unit
blurred vision, high count of a certain white blood cell (eosinophilia), stomach problems (gastritis), joint pain (arthralgia), trouble sleeping (insomnia), and toothache.Eosinophilic Esophagitis: injection site reactions, upper respiratory tract infections, cold sores in your mouth or
More news about: Sanofi
Feb 06, 2026, 06:59 ET Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
intestinal anastomoses, inflammatory bowel disease). Signs may be masked.Behavioral and Mood Disturbances: May include euphoria, insomnia, mood swings, personality changes, depression, and psychosis. Advise patients to seek medical attention if symptoms develop or worsen.Effects
More news about: Aucta Pharmaceuticals, Inc.
Feb 02, 2026, 10:15 ET Kong to Unveil AI Connectivity Vision and Roadmap to Power the Agentic Era
MCP testing in Insomnia,
More news about: Kong Inc.
Jan 29, 2026, 10:06 ET Sprout Pharmaceuticals' Addyi® (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards
concentrations.Most Common Adverse ReactionsMost common adverse reactions (incidence ≥2%) are dizziness, somnolence, nausea, fatigue, insomnia, urinary tract infection, anxiety, sinusitis, constipation, and dry mouth.See Full Prescribing Information and Medication Guide, including
More news about: Sprout Pharmaceuticals
Jan 22, 2026, 08:56 ET South Shores Detox Leads Public Education Efforts on Rising Kratom Abuse in California
kratom withdrawal symptoms, which can include muscle aches, insomnia, irritability, and intense cravings. Many patients initially used kratom for pain management or to self-treat opioid withdrawal, only to develop a
More news about: South Shores Detox
Jan 21, 2026, 09:00 ET Insomnia Cookies Launches First-Ever Pop-Up Date Night Reservations, Plus New Valentine's Day Cookies & Dips of Your Dreams
Download Insomnia Cookies images here. About Insomnia Cookies Insomnia Cookies is a rapidly expanding late-night bakery concept headquartered in Philadelphia, PA. Founded at the University of Pennsylvania by then-student Seth Berkowitz, Insomnia Cookies has been
More news about: Insomnia Cookies
Jan 20, 2026, 08:00 ET Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.
More news about: Lipocine Inc.
Jan 16, 2026, 10:51 ET Melatonin Supplements Market Projected to Reach USD 13.1 Billion by 2035 amid Surging Global Demand for Natural Sleep Solutions
According Future Market Insights (FMI) leading wellness segments, including insomnia management and stress relief, drive a 14.9% CAGR as the industry transitions from niche adoption to mainstream pharmaceutical integration.As
More news about: Future Market Insights
Jan 16, 2026, 08:31 ET Menoveda Celebrates Empowering Women Through Increased Menopause Awareness During the Holiday Season
range of symptoms that can come with menopause. Night sweats and hot flashes are stereotypical factors, but mood changes, incontinence, headaches, and insomnia are among a plethora of other potential symptoms.All of this is par for the course for Singh and her team. Menoveda was established in 2022
More news about: Menoveda
Jan 14, 2026, 16:30 ET TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
tract infection. The most common adverse reactions with combination therapy (≥20% for any combination) include fatigue, nausea, diarrhea, dyspnea, insomnia, headache, rash, pyrexia, cough, muscle spasms, back pain, vomiting, hypertension, musculoskeletal pain, upper respiratory tract infection, , peripheral
More news about: Johnson & Johnson
Jan 13, 2026, 08:05 ET Kye Pharmaceuticals Announces Licensing and Distribution Agreement with Neurim Pharmaceuticals for SLENYTO® in Canada
processes and roughly 300–500 children in Canada aged 1–17 may have SMS in 2025 [2, 3].Between 50-80% of children with ASD & SMS suffer from insomnia, much more than typically developing children [4]. Sleep disturbances can negatively impact components of executive function, such as intellectual
More news about: Kye Pharmaceuticals Inc.
Jan 13, 2026, 08:00 ET Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting
care.13MDD often includes sleep disturbances such as insomnia or hypersomnia, with approximately 60 percent of MDD patients experiencing clinically relevant insomnia symptoms despite being on an SSRI/SNRI.14 Disturbed sleep and insomnia symptoms have a significant impact on a patient's
More news about: Johnson & Johnson
Jan 12, 2026, 08:00 ET Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.
More news about: Lipocine Inc.
Jan 11, 2026, 08:53 ET UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026
parasympathetic nervous system, easing stress and improving blood flow—without electronics or medication.→ Ideal for: individuals with insomnia, migraines, eye fatigue, frequent travelers, and stressed professionals.2. UOG 5-in-All Wellness Foot Pain Relief & Diabetic Support
More news about: United One Group (UOG) America
Dec 18, 2025, 08:49 ET Participant Shares Results Following 5-Step Sleep Tantra Seminar on MyTSV.com
a critical public health concern. According to research published by the National Council on Aging, nearly 50% of older adults report symptoms of insomnia, significantly impacting their cognitive function and quality of life [1]. Addressing this widespread issue, MyTSV.com has released a compelling new
More news about: MyTSV
Dec 16, 2025, 08:00 ET Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone
Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.
More news about: Lipocine Inc.
Dec 15, 2025, 11:01 ET Day & night: Cancer disrupts the brain's natural rhythm
release, reducing quality of life and increasing mortality.Disruptions to our own diurnal rhythms have been linked to stress responses like insomnia and anxiety—both common among cancer patients. The body depends on a feedback loop called the HPA axis to maintain healthy stress hormone levels.
More news about: Cold Spring Harbor Laboratory
Dec 05, 2025, 09:00 ET Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting
than placebo) include transaminase elevations; somnolence; decreased appetite; diarrhea; pyrexia; vomiting; fatigue, malaise, and asthenia; rash; insomnia, sleep disorder and poor-quality sleep; and infections. Hematologic abnormalities were also observed.PREGNANCY:EPIDIOLEX should
More news about: Jazz Pharmaceuticals plc
Dec 04, 2025, 08:12 ET UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
trial, adverse reactions were generally similar to those observed and attributed to drug in adjunctive placebo-controlled trials, with the exception of insomnia (observed at a higher rate of ≥2%). Pediatric adverse reactions were similar to those seen in adult patients.Primary Generalized Tonic-Clonic
More news about: UCB